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092 The Journal of Thoracic and Cardbjective: Congenital heart diseases in pediatric patients are associated with a wide
ariety of extracardiac thoracic vascular abnormalities. This study analyzed the
alue of gadolinium-enhanced magnetic resonance angiography during quiet free
reathing for assessing extracardiac thoracic vascular abnormalities in young chil-
ren with congenital heart diseases.
ethods: Fifty-three children with congenital heart diseases (age range, 1 day-40
onths; mean, 10.9 months) associated with extracardiac thoracic vascular abnor-
alities who had undergone both free-breathing, gadolinium-enhanced magnetic
esonance angiography and cardiac catheterization, surgical intervention, or both
ithin 2 weeks were reviewed. Diagnostic findings on gadolinium-enhanced mag-
etic resonance angiography among patients grouped according to 3 major condi-
ions of conotruncal abnormalities (n  33), aortic or venous abnormalities (n 
1), and pulmonary vascular abnormalities (n  9), as well as associated extracar-
iac thoracic vascular abnormality findings, were compared with findings made by
sing cardiac catheterization, surgical intervention, or both.
esults: Extracardiac thoracic vascular abnormality findings on gadolinium-
nhanced magnetic resonance angiography were similar to those on catheterization,
urgical intervention, or both in patients with conotruncal abnormalities (124 vs 127,
 .083), aortic or venous abnormalities (36 vs 33, P  .083), and pulmonary
ascular abnormalities (24 vs 25, P  .317). The overall sensitivity of gadolinium-
nhanced magnetic resonance angiography for detection of these lesions identified
y means of catheterization, surgical intervention, or both was 97.9%. However,
adolinium-enhanced magnetic resonance angiography revealed 11 additional ex-
racardiac thoracic vascular abnormalities that were not found on cardiac catheter-
zation. The  coefficient for the correlation of image quality and diagnostic value of
adolinium-enhanced magnetic resonance angiography by using a 4-point-scale (1 
ondiagnostic to 4  excellent) assessed by 2 independent reviewers was excellent
mean score  3.66), with superb interobserver agreement (  0.727-0.874).
onclusions: Free-breathing, gadolinium-enhanced magnetic resonance angiogra-
hy is clinically feasible for detailed anatomic delineation and treatment planning of
arious extracardiac thoracic vascular abnormalities in young children with con-
enital heart diseases.
chocardiography and cardiac catheterization are among the mainstays of
diagnosis of cardiovascular diseases.1-6 The low cost, noninvasiveness, an
bedside portability of echocardiography make it ideally suited for use innfants and children. In many conditions echocardiography is the only imaging modal-
iovascular Surgery ● November 2006
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Dty needed for diagnosis. However, the diagnostic value of
chocardiography might occasionally be compromised by
nterference from the thoracic cage or aerated lung paren-
hyma, and the incidence of clinically important diagnostic
rrors is higher in infants who weigh more than 2.5 kg2,3 In
atients with complex congenital heart diseases (CHDs)
ssociated with extracardiac thoracic vascular abnormalities
ETVAs), sole echocardiographic evaluation might not pro-
ide adequately comprehensive anatomic demonstration for
urgical planning.2-5 Cardiac catheterization is an invasi
rocedure involving radiation exposure and injection of
odinated contrast agent and can be associated with a small
ut definable morbidity and mortality.6 A review of 495
onsecutive pediatric catheterization procedures found one
r more complications occurred in 436 (8.8%) procedur7
urthermore, because of small body size, only a limited
mount of contrast agent can be used in infants and small
hildren with CHDs, and a good cardiac catheterization
tudy might be difficult.4,6 Three-dimensional gadolinium-
nhanced magnetic resonance angiography (GEMRA) has
een reported to be a comprehensive and noninvasive alter-
ative to diagnostic catheterization for the evaluation of the
horacic aorta.8-10 Great success with breath-holding GEMRA
as been reported in the assessment of CHDs, aortic arch
nomalies, and complex pulmonary arterial and venous
tenosis or atresia and demonstration of collateral arter-
es.10-17 The patients in most of these studies were adul
ouths who could cooperate, whereas general anesthesia
ith intubation and temporary suspension of ventilation
uring GEMRA was applied for small children who were
nable to cooperate. However, hypotension can occur, and
notropic support might be needed after induction of anes-
hesia in small children with CHDs.18 Furthermore, an an-
sthesiologist might not always be available in the magnetic
esonance imaging room. Free-breathing GEMRA studies
n pediatric patients have not been well addressed.11,19 The
resent study investigated the clinical feasibility of quiet
ree-breathing GEMRA during light anesthesia for evaluat-
Abbreviations and Acronyms
CHD  congenital heart disease
ETVA  extracardiac thoracic vascular abnormality
GEMRA gadolinium-enhanced magnetic resonance
angiography
MAPCA major aortopulmonary collateral artery
PAPVR  partial anomalous pulmonary venous return
SVC  superior vena cava
TAPVR  total anomalous pulmonary venous return
TGA  transposition of the great arteries
ToF  tetralogy of Fallotng ETVAs in small children with CHDs and compared its f
The Journal of Thoracicr
ndings with those of cardiac catheterization, surgical in-
ervention, or both.
ethods
atients
ll children less than 4 years of age referred to our department for
ardiovascular magnetic resonance examination from January 1,
000, to June 30, 2005, who fulfilled the following criteria were
ncluded in this study: (1) diagnosis of CHD with cardiovascular
efects (atrial or ventricular septal defect, patent ductus arteriosus,
bnormal cardiac chambers, and/or valvular abnormalities) that
equired interventional or surgical treatment; (2) suspected asso-
iation with ETVAs (conotruncal, aortic, central venous, and/or
ulmonary arterial or venous lesions); (3) underwent quiet free-
reathing GEMRA; and (4) underwent cardiac catheterization,
urgical confirmation, or both within 2 weeks of the GEMRA
tudy. All GEMRA studies were clinically indicated for detailed
natomic delineation of ETVAs. This retrospective study was
pproved by the institutional review board of our hospital, includ-
ng the use of data obtained by searching of computer databases
nd the review of medical records.
hree-dimensional GEMRA
nformed parental consent for GEMRA was obtained, and all
xaminations were performed with a 1.5-T superconducting mag-
etic resonance system (Signa Horizon LX EchoSpeed 8.1/8.3
perating System; GE Healthcare, Milwaukee, Wis). Intravenous
ccess was established with a 22- or 24-gauge intravenous cannula
nserted into a peripheral vein. Light anesthesia was routinely
pplied by means of administration of oral choral hydrate (75
g/kg, maximal dose was 2000 mg). If not successful, intravenous
etamine (1 mg/kg) and atropine (0.01 mg/kg) were administered.
he oxygen saturation and heart rate of the lightly sedated patients
ere continuously monitored with a peripheral gating clamp fixed
t the thumb or middle finger. A head coil was used in patients
eighing less than or equal to 10 kg. A cardiac phase-array coil
as used in those weighing greater than 10 kg. Localizing images
ere obtained in the coronal plane with the center at the midthorax
y using a fast spoiled-gradient echo-recall sequence. Afterward,
ree-breathing GEMRA was performed with a nonelectrocardiogram–
riggered, 3-dimensional, spoiled gradient–recalled echocardio-
raphic pulse sequence with the following parameters: flip angles
f 45°; repetition time of 5.5 to 7.8 ms; echocardiographic time of
.2 to 2.5 ms; number of excitations of 1; rectangular field of view
ith maximum dimension of 16 to 28 cm depending on body size;
56  128 matrix; centric k-space filling; sampling bandwidth of
1.2 kHz; slab thickness of 8 to 12 cm with 50 to 70 partitions,
ffective slice thickness of 1.5 to 2.2 mm; and acquisition time of
0 to 45 seconds. Gadopentate dimeglumine (0.2 mmol/kg body
eight; Magnevist, Schering, Berlin, Germany) was administered
y means of manual injection through the peripheral cannula and
ollowed by saline flushing. Because of the presence of CHDs with
ntracardiac or extracardiac shunts, as well as fast heart rates in
mall children, the “best guess” method with a delay time of 6 to
 seconds was used.14,20,21 Three uninterrupted sequential acqu-
itions were performed with quiet breathing.
After the examination, the raw data were immediately trans-
erred to a commercially available workstation (Advantage Work-
and Cardiovascular Surgery ● Volume 132, Number 5 1093
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Dtation, AW 4.0, GE Healthcare). Postprocessing of GEMRA with
ultiplanar reconstructions, 2-dimensional composite and subvol-
me maximal intensity projections, and 3-dimensional projection
ngiograms created with surface-shaded rendering techniques to
est depict particular anatomic features of interest was used. User-
efined subvolume maximal intensity projection images were used
o assess the extent of stenosis. Data segmentation methods were
sed to remove unnecessary overlapping structures so that the
egions of interest were clearly shown. Two radiologists blinded to
he clinical status of the patients were asked to reformat and
nalyze the images independently. Disagreements were resolved
y consensus. The time devoted to the analysis of each case was
pproximately 30 minutes.
The ETVAs were divided into 3 main categories: (1) conotrun-
al developmental abnormalities; (2) aortic or central venous de-
elopmental abnormalities; and (3) pulmonary vascular develop-
ental abnormalities. For conotruncal lesions, the following anatomic
bnormalities were investigated: findings compatible with dextro- or
evo-transposition of the great arteries (D-TGA or L-TGA); tetralogy
f Fallot (ToF), the status of pulmonary arteries and confluence,
ach individual major aortopulmonary collateral artery (MAPCA;
2 mm in diameter), or the presence of clustered multiple small
ortopulmonary collateral arteries (each with diameter 2 mm)
nd abnormal operative shunts; interrupted aortic arch; right aortic
rch; double-outlet right ventricle; truncus arteriosus; and aorto-
ulmonary window or fenestration. For aortic or central venous
esions, the following anatomic abnormalities were investigated:
ndings compatible with coarctation of the aorta and collaterals;
nomalous aortic branching (eg, aberrant right or left subclavian
rtery, retroesophageal aortic diverticulum, and mirror-image
ranching); or central venous lesions (eg, abnormal superior vena
ava [SVC] or inferior vena cava and abnormal azygos or hemi-
zygos veins). For pulmonary vascular abnormalities, the follow-
ng anatomic abnormalities were investigated: findings compatible
ith main, right, or left pulmonary artery atresia or stenosis; the
bsence of pulmonary arterial confluence, and partial anomalous
ulmonary venous return (PAPVR) or total anomalous pulmonary
enous return (TAPVR). In each case abnormal widening, narrow-
ng, or occlusion of the vessels or shunts and other associated
nomalous vascular structures were also recorded.
ardiac Catheterization/Surgical Findings
ardiac catheterization examinations were performed by experi-
nced pediatric cardiologists using a BH 5000 system (Philips
edical Systems, Best, The Netherlands). Aortography, ventricu-
ography, and study of pulmonary arteries were performed rou-
inely. Wedged pulmonary venography and selective catheterization
f the carotid, subclavian, and MAPCA arteries were performed as
eeded. A pediatric cardiologist who was unaware of the magnetic
esonance angiography findings reviewed the cardiac catheteriza-
ion images, and the number of ETVAs was determined by using
similar methodology as for GEMRA. For those patients who did
ot undergo surgical correction, GEMRA was compared with
ardiac catheterization findings. For surgical patients (without or
ith prior cardiac catheterization studies), GEMRA was primarily
ompared with surgical observations, and the surgical records were
ointly reviewed by a radiologist and a cardiovascular surgeon. c
094 The Journal of Thoracic and Cardiovascular Surgery ● Novtatistical Analysis
he number of ETVAs, including the anatomic variables described
bove in each category, and the associated vascular lesions re-
ealed on GEMRA in each patient were compared with the find-
ngs on cardiac catheterization, surgical intervention, or both by
sing the nonparametric paired Wilcoxon signed-rank test.
ssessment of Imaging Quality and Clinical Feasibility
he assessment of the overall quality of 3-dimensional GEMRA
including the presence or absence of motion artifact, the continu-
ty of the vessels, and the sharpness and demarcation of the
ascular outline) and clinical value were subjectively graded on a
-point-scale as follows: 1, poor quality and inadequate informa-
ion for answering clinical queries and making decisions about
urther treatment; 2, fair quality but with inadequate information
or answering clinical queries and making decisions about further
reatment; 3, good quality and adequate information for answering
linical queries and making decisions about further treatment; and
, excellent quality with adequate information for answering clin-
cal queries and making decisions about further treatment. The
EMRA-reformatted images were rated by a cardiovascular sur-
eon and then independently rated by a radiologist who did not
erform the image processing. The interobserver agreement of the
uality scores was evaluated with the  coefficient. The degree of
oncordance was considered to be “poor” when the  value was
ess than 0.2, “fair” when the  value was 0.2 or greater to less than
.4, “moderate” when the  value was 0.4 or greater to less than
.6, “good” when the  was 0.6 or greater to less than 0.8, and
excellent” when the  value was 0.8 or greater to 1.0.
esults
total of 53 patients (20 female and 33 male patients; age
ange, 1 day-40 months; mean, 10.9 months) met the inclu-
ion criteria for the study. The major diagnoses among
atients in the conotruncal developmental, aortic or venous
evelopmental, and pulmonary vascular abnormality groups
nd their associated ETVAs are summarized in Tables E1
hrough E3. Conotruncal abnormalities were diagnosed
3 patients (11 with D-TGA or L-TGA, 13 with ToF, 2 with
nterrupted aortic arch, 2 with right aortic arch, 1 with
ouble-outlet right ventricle, 2 with truncus arteriosus, 1
ith aortopulmonary fenestration, and 1 with aortopulmo-
ary window), aortic or venous developmental abnormali-
ies were diagnosed in 11 patients (7 with coarctation of the
orta, 2 with anomalous aortic branches, 1 with a double
VC and the persistent left SVC draining to a dilated
oronary sinus, and 1 with left isomerism), and pulmonary
rterial or venous abnormalities were diagnosed in 9 pa-
ients (6 with pulmonary atresia or stenosis, 1 with widened
ulmonary artery and pulmonary valve dysplasia, 1 with
APVR, and 1 with TAPVR). In 44 patients GEMRA was
ccomplished by using oral choral hydrate only. However,
nadequate sedation with choral hydrate led to aborted stud-
es in 9 patients, and successful repeated studies were
chieved on the next day by using intravenous ketamine. No
onversion to general anesthesia was needed. None of the
ember 2006
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Datients had any sedation-related complications, and neither
dditional respiratory nor inotropic support was required.
etection of Associated Extracardiac Vascular
bnormalities
he numbers of extracardiac vascular abnormalities found
n GEMRA, cardiac catheterization, and/or surgical inter-
ention are summarized in Tables E1 through E3. There was
o significant difference in the detection of abnormalities
n GEMRA versus catheterization, surgical intervention,
r both in the conotruncal abnormalities group (124 vs
27, P  .083), aortic or venous abnormalities group (36 vs
3, P  .083), and pulmonary abnormalities group (24 vs 25,
 .317).
In the conotruncal abnormalities group 18 of 33 patients
nderwent both cardiac catheterization and surgical inter-
ention. Among these 18 patients, except for multiple small
APCAs that were not visible on GEMRA in 2 patients,
EMRA revealed all abnormalities diagnosed on catheter-
zation in the other 16 patients, as well as 7 additional abnor-
alities (1 pulmonary stenosis, 3 MAPCAs, 1 TAPVR, 1
APVR, and 1 aberrant right subclavian artery) that were all
onfirmed on subsequent operations. In the remaining 15
atients, GEMRA also revealed all vascular abnormalities
een on catheterization or surgical intervention (Figure 
xcept for one mild supravalvular pulmonary stenosis in a
atients with D-TGA postaortopulmonary switch.
In the aortic or venous abnormalities group, only 3 of 11
atients underwent both cardiac catheterization and surgical
ntervention, and GEMRA revealed all abnormalities found
n catheterization and surgical intervention. In the remain-
ng 8 patients, GEMRA also revealed all vascular abnor-
alities seen on catheterization, as well as 3 additional
bnormalities (1 aberrant left subclavian artery, 1 subcla-
ian steal caused by severe innominate stenosis, and 1
emiazygal continuation to persistent left SVC; Figure 
In the pulmonary vascular abnormalities group, only 2 of
patients underwent both cardiac catheterization and sur-
ical intervention, whereas pulmonary valve dysplasia in 1
atent was not visible on GEMRA. Among the remaining 7
atients (4 underwent catheterization only, and 3 underwent
urgical intervention directly after GEMRA), all lesions
ound on catheterization or surgical intervention were ac-
urately revealed on GEMRA (Figure E2).
Compared with the number of abnormalities revealed
n cardiac catheterization, surgical intervention, or both,
EMRA exhibited 97.6%, 100%, and 96% sensitivities in
etection of conotruncal, aortic or venous, and pulmonary
ascular abnormalities, respectively, with an overall sensi-
ivity of 97.9%. Furthermore, 11 additional ETVAs were
evealed on GEMRA that were not found on cardiac cathe-
erization. G
The Journal of Thoracicmage Quality and Clinical Feasibility
EMRA was considered diagnostic in all 53 patients with
ood to excellent quality and mean quality scores for
onotruncal, aortic or venous, and pulmonary vascular ab-
ormalities of 3.60, 3.75, and 3.71, respectively. Excellent
nterobserver correlations of quality scores for conotruncal
bnormalities (  0.874, P  .001), aortic or venous
bnormalities (  0.744, P  .011), and pulmonary vas-
ular abnormalities (  0.727, P  .023) were found
etween the 2 raters. These results validated the clinical
easibility of GEMRA during light anesthesia and free
reathing in the assessment of various ETVAs in neonates,
nfants, and young children with CHDs.
iscussion
pin-echocardiographic and gradient-recalled magnetic res-
nance sequences can offer clear demonstration of thoracic
ascular abnormalities but are limited by long scanning
ime, the requirement for multiple breath holds, low spatial
esolution, turbulent flow, slow flow, and underlying con-
itions, such as arrhythmia, severe pulmonary disease, and
oor cooperation.1-6,8-10,22,23 GEMRA has shown grea
romise in the evaluation of thoracic vessels, even for
atients with low cardiac output or severely altered hemo-
ynamics, by virtue of rapid T1 shortening of blood with
aramagnetic agents (gadolinium) by considerable reduc-
ion of acquisition times and high signal-to-noise ratio,
referential enhancement of arteries, elimination of turbu-
ent artifacts, larger volume of acquisition, and multiplanar
apabilities.10-17
GEMRA is highly accurate in the evaluation of aortic
oarctation, complex pulmonary arterial stenosis and atresia,
ystemic and pulmonary venous anomalies, and MAPCAs.
ost studies of GEMRA have emphasized breath holding
uring the examination.10-17 In pediatric patients, howeve
specially in neonates or infants, GEMRA is typically con-
ucted during general anesthesia, with ventilation sus-
ended during imaging.12-18 Anesthetizing pediatric pa-
ients with CHDs for cardiac magnetic resonance imaging
oses many challenges for the anesthesiologist. Although
omplications are rare, general anesthesia carries potential
isks, especially in small children, because a longer con-
ecting tube from the patient to the ventilator within the
agnetic resonance gantry is required. In addition, low
ardiac output, necessity for administration of an inotropic
gent after anesthesia induction, and transient hypotension
ight be encountered.18 Furthermore, the cost entailed f
eneral anesthesia for magnetic resonance imaging is much
igher than for free-breathing light anesthesia (approxi-
ately $350-$450 vs $10-$20 in our hospital). GEMRA
uring spontaneous breathing with inhalation of sevoflurane
or anesthesia of children has been reported.11 In this study
EMRA was performed during free-breathing light anes-
and Cardiovascular Surgery ● Volume 132, Number 5 1095
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Dhesia by using oral choral hydrate first and, if not success-
ul, subsequent intravenous administration of ketamine. The
xaminations were successfully performed in all patients
ithout any complications. The results showed that free-
reathing GEMRA is also a clinically feasible method with
igh sensitivity (97.9%) for the evaluation of ETVAs and no
ignificant difference in findings compared with catheter-
zation, surgical intervention, or both. However, for young
hildren with CHDs who are ventilator dependent or have
evere congestive heart failure or marked pulmonary
ypertension and in whom intravenous administration of
etamine and atropine is not appropriate, free-breathing
EMRA is hindered.
Conotruncal abnormalities are related to abnormal divi-
ion or rotation of the primitive truncus during embryologic
evelopment. Standard spin-echocardiographic and gradi- s
096 The Journal of Thoracic and Cardiovascular Surgery ● Novnt-echocardiographic techniques can effectively depict the
natomic relationship between the aorta and the pulmonary
rtery.24 This study has demonstrated that GEMRA 
ighly accurate in the diagnosis of various conotruncal
bnormalities, including D-TGA or L-TGA, ToF, inter-
upted aorta, right aortic arch, double-outlet right ventricle,
runcus arteriosus, aortopulmonary window, and even small
ortopulmonary fenestration in young children. Pulmonary
tenoses and associated aortic, venous, and pulmonary
TVAs were clearly shown by GEMRA in all of our pa-
ients with TGA, except in one who had received an arterial
witch procedure in another hospital and had a mild supra-
alvular pulmonary stenosis, which was overlooked. The
mportance of multiplanar assessment of GEMRA for fol-
ow-up examinations of TGA after arterial switch has been
Figure 1. A 28-month-old boy with angiographi-
cally proved segmental aortic coarctation associ-
ated with right innominate artery occlusion and
subclavian steal phenomenon. A and B, Coronal
and sagittal aortograms show aortic coarctation
(CoA) just beyond the dilated left subclavian aorta
and the dilated proximal right innominate artery
(InA) with abrupt occlusion. C and D, GEMRA in
coronal and sagittal subvolume maximal intensity
projection images clearly reveal coarctation (CoA)
and prominent collateral arterial supplies from the
descending aorta. Note occlusion of the right in-
nominate artery (InA) with proximal dilatation and
elucidation of the subclavian steal phenomenon
(ScS), which was not seen on aortograms.tressed because pulmonary artery stenoses are usually
ember 2006
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Dvoid shaped and might erroneously be interpreted as nor-
al in some views.25
Previous studies have shown that GEMRA is a robust
ethod, with 100% sensitivity for delineation of all sources
f pulmonary blood supplies in patients with complex pul-
onary stenosis and atresia, such as ToF, as well as various
ulmonary and systemic venous anomalies.12-15 Prasad and
ssociates12 reported that all MAPCAs with diameters 
.5 mm or greater and clusters of smaller MAPCAs were
iagnosed on GEMRA, and results showed excellent corre-
ation with cardiac catheterization. Geva and colleague14
nd Greil and coworkers13 reported that the good signal-t
oise ratio of GEMRA results in high-resolution demonstra-
ion of small vessels down to 0.5 mm in diameter. Excellent
orrelation between GEMRA and angiographic measure-
ents of congenital stenoses in small pulmonary arteries
as also been reported.15 In this study GEMRA perform
uring light anesthesia in young children identified all
APCAs with a diameter of 2 mm or greater. Although
mall clusters of MAPCAs were not visible in 2 cases in the
resent study, this did not affect the treatment or outcome
ecause the affected vessels were too small and had slow
lood flow. On the other hand, GEMRA is helpful by
roviding an anatomic road map for coil embolization of
igh-flow MAPCAs, which might generate pulmonary
vercirculation.13,14
This study found that even for children less than 40
onths old, GEMRA was 100% sensitive in differentiation
f segmental narrowing or tubular hypoplasia of aortic
oarctation, evaluation of collateral supplies, and depiction
f associated anomalies, including Kommerell’s diverticu-
um, aberrant subclavian artery, and mirror-image branch-
ng. Moreover, a total of 3 uninterrupted sequential acqui-
itions were routinely obtained from our patients, allowing
omprehensive investigation of venous abnormalities, such
s persistent left SVC, interrupted IVC with hemiazygos
ontinuation, and unusual delayed arterial perfusion with
ubclavian steal phenomenon. GEMRA also provides accu-
ate quantitative anatomic information of the aorta in chil-
ren with CHDs, which is well correlated with conventional
ngiographic data and can therefore be used for planning
atheter-guided procedures.16 GEMRA has the advantage 
eing a radiation-free tool for follow-up of patients with
ortic coarctation after transcatheter dilatation or surgical
epair, who are expected to require lifelong surveillance,
nd this might be especially important for those who un-
ergo repair in infancy and young childhood and are thus
ore likely to have recurrent coarctation or aneurysm
ormation.17
Three-dimensional GEMRA data sets should be acquired
o match to k-space reconstruction and to synchronize peak
ontrast concentration in the target vessels during data ac-
uisition to obtain optimal vascular enhancement.15,26,27 A s
The Journal of Thoracicontrast dose of 0.2 mmol/kg body weight was routinely
sed in this study to obtain a high signal-to-noise ratio, even
uring free breathing.19 For image acquisition, automated trig-
ering with bolus tracking or timing with a time-intensity
urve after a test bolus was not used in this study. Fast heart
ates, as well as the presence of various complex intracar-
iac and extracardiac shunts, limited the application of such
riggering methods in this cohort of young children, neces-
itating the use of only a small amount of contrast agent.
irculation times determined during end-inspiration breath
old might differ from those obtained during free breathing
y as much as 6 seconds in an individual patient.27 The
best guess” method with initiation of the acquisition ap-
roximately 6 to 8 seconds after manual injection of con-
rast medium injection can provide high-quality GEMRA
mages.14,20,21 The  coefficient for correlation of the ima
uality and diagnostic value of GEMRA during light anes-
hesia, as assessed by 2 independent reviewers, in this study
evealed excellent image quality (mean score  3.66) with
uperb interobserver agreement (  0.727-0.874). This
nding validates the feasibility of this method for evaluation
f a wide spectrum of ETVAs in young children with
HDs.
imitations
his study had several limitations. Not all patients under-
ent both cardiac catheterization and surgical intervention,
hich would not have been practical and ethical in some
atients who could be adequately managed with a single
nterventional treatment. On the other hand, some of our
atients underwent operations directly after GEMRA, which
erved as an excellent tool for surgical planning. The sample
ize was small in each of the 3 major diagnostic groups in
his study, and the spectrum of ETVAs in these patients was
ide. However, the inclusion criteria required cardiac cath-
terization, surgical intervention, or both in all selected
ases so that GEMRA findings could confidently be con-
rmed. The quality score and clinical feasibility of GEMRA
ated by a cardiovascular surgeon and a radiologist in this
tudy were based on the GEMRA-reformatted images, and
hese evaluators did not perform postprocessing image re-
onstructions. Although the GEMRA findings might have
een influenced by the radiologist who performed the image
econstructions, this method was necessary to ensure that
hese evaluators were truly blinded to the image findings
efore assessment.
onclusions
ree-breathing GEMRA is clinically feasible for compre-
ensive anatomic delineation of a wide spectrum of ETVAs
n young children with CHDs, facilitating transcatheter or
urgical treatment.
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Digure E1. A 5-day-old boy with tetralogy of Fallot underwent
urgical intervention directly after gadolinium-enhanced mag-
etic resonance angiography. Gadolinium-enhanced magnetic
esonance angiography in coronal subvolume maximal intensity
rojection image reveals the right aortic arch (RAA) from a major
ortopulmonary collateral artery (MAPCA), which runs a tortuous
ourse and then connects to the proximal part of the right pul-
onary artery (RPA). Note mild confluence narrowing (CN) and
istal RPA stenosis (RPASt).
Figure E2. A 4-day-old girl with infradiaphragmatic total anoma-
lous pulmonary venous return (TAPVR) underwent surgical inter-
vention directly after gadolinium-enhanced magnetic resonance
angiography. Gadolinium-enhanced magnetic resonance angiog-
raphy in coronal subvolume maximal intensity projection image
reveals that the pulmonary veins (PV) join into a common trunk
(TAPVR), which subsequently drains into the portal vein (PoV).
RUPV, right upper pulmonary vein; RLPV, right lower pulmonary
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DABLE E1. Summary of conotruncal developmental abnormalities and associated vascular abnormalities in 33 young
atients with congenital heart diseases
ase no. Age/sex Major diagnosis Associated findings Prior procedures MRA
Catheterization/
operation
ransposition of the great arteries
1 2 mo/F D-TGA PS, PDA 3 3/N
2 3 mo/F D-TGA PS, PDA 3 2/3
3 5 mo/F D-TGA PS, RAA 3 3/N
4 9 mo/M D-TGA PS, PDA, DSVC 4 4/N
5 37 mo/M D-TGA PS, small MPA, RPA and LPA
stenoses, MAPCAs (3)
8 7/8
6 11 mo/F D-TGA PS BTS 2 2/2
7 23 mo/F D-TGA after switch PS AP switch 1 2/N
8 3 d/M D-TGA Widened MPA, PDA 3 3/N
9 2 mo/M D-TGA Widened MPA, CoA with
hypoplastic arch, ARSA
4 4/4
10 6 mo/M L-TGA PS, DSVC, TAPVR 4 3/4
11 3 mo/F L-TGA PS, PDA, RAA 4 4/4
etralogy of Fallot
12 2 mo/F ToF PAt, C, CN, MAPCAs (2), RAA,
RPA stenosis, DSVC
7 N/7
13 1 d/M ToF PAt, C, MAPCAs (2) 3 3/N
14 5 d/M ToF PAt, C, CN, RPA stenosis,
RAA, MAPCA (1)
5 N/5
15 25 mo/M ToF PAt, C, CN, MAPCAs (2) BTS 4 4/4
16 4 mo/M ToF PAt, C, MAPCAs (3) 5 4/5
17 11 mo/F ToF PAt, C, MAPCAs (3Mu) BTS 6 5/6
18 7 mo/F ToF PAt, C, MAPCAs (2) BTS 4 4/4
19 24 mo/M ToF PAt, C, shunt aneurysm, PDA Waterston shunt 4 4/4
20 38 mo/M ToF PAt, C, conduit stenosis, RPA
aneurysm, MAPCA (1Mu)
Rastelli procedure 5 6/6
21 1 mo/M ToF PS, C, PDA, MAPCAs (2 Mu) 4 5/5
22 15 mo/M ToF PS, C, MAPCAs (2), PAPVR 4 3/4
23 22 mo/M ToF PS, C, BTS stenosis, DSVC,
large coronary sinus
BTS 4 4/4
24 12 mo/M ToF PS, C, BTS stenosis, DSVC,
RAA, RAD, ALSA
BTS 6 N/6
thers
25 1 mo/F Interrupted aortic arch Numerous collateral vessels 2 2/N
26 3 d/M Interrupted aortic arch Descending aorta from PDA, left
innominate artery
3 N/3
27 2 wk/F RAA, RAD, ALSA 3 3/N
28 3 wk/M RAA, mirror-image branching 3 N/3
29 18 mo/F Double-outlet right ventricle IVC agenesis, azygos and
hemiazygos continuation
4 4/N
30 2 wk/F Type 2 truncus PDA replaced arch, ARSA 3 3/3
31 39 mo/M Type 4 truncus RAA, RPA aneurysm 3 3/N
32 9 mo/M AP fenestration 1 1/1
33 5 d/M AP window ARSA 2 1/2
RA, Number of abnormalities seen on magnetic resonance angiography; Catheterization/operation, number of abnormalities seen on cardiac catheter-
zation, surgical intervention, or both; D-TGA, dexo-transposition of great arteries; PS, pulmonary stenosis; PDA, patent ductus arteriosus; N, not performed;
AA, right aortic arch; DSVC, double superior venae cavae; MPA, main pulmonary artery; RPA, right pulmonary artery; LPA, left pulmonary artery; MAPCA,
ajor aortopulmonary collateral artery (numbers in parentheses indicate numbers of MAPCAs); BTS, Blalock-Taussig shunt; AP, aorto-pulmonary; CoA,
oarctation of aorta; ARSA, aberrant right subclavian artery; L-TGA, levo-transposition of the great arteries; TAPVR, total anomalous pulmonary venous
eturn; ToF, tetralogy of Fallot; PAt, pulmonary atresia; C, presence of pulmonary confluence; CN, confluence narrowing; C, absence of pulmonary
onfluence; Mu, multiple small aortopulmonary collateral arteries; PAPVR, partial anomalous pulmonary venous return; RAD, retroesophageal aortic
iverticulum, ALSA, aberrant left subclavian artery; IVC, inferior vena cava.
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DABLE E2. Summary of aortic or venous developmental abnormalities and associated vascular abnormalities in 11 young
atients with congenital heart diseases
ase no. Age/sex Major diagnosis Associated findings MRA
Catheterization/
operation
oarctation of aorta
1 24 mo/M CoA (segmental) PDA 2 2/N
2 4 mo/M CoA (segmental) PDA, ARSA, DSVC 4 4/N
3 11 mo/F CoA (segmental) PS, RAA, ALSA 4 3/N
4 28 mo/M CoA (segmental) Dilated LSA, multiple collaterals, right
inominate arterial occlusion, subclavian steal
5 4/N
5 5 mo/F CoA (hypoplastic arch) Dilated LSA, multiple collaterals 3 3/3
6 2 wk/M CoA (hypoplastic arch) Dilated LSA, multiple collaterals 3 3/3
7 13 mo/M CoA (hypoplastic arch) Dilated LSA, multiple collaterals, DSVC 4 4/4
nomalous aortic branching or veins
8 27 mo/M RAD, ARSA 2 2/N
9 1 wk/M RAD, ARSA 2 2/N
10 36 mo/F DSVC, LSVC to dilated coronary sinus 2 2/N
11 4 mo/F Left isomerism Interrupted IVC, hemiazygos continuation,
DSVC, RAA, bilateral epbronchial PA
5 4/N
RA, Number of abnormalities seen on magnetic resonance angiography; Catheterization/operation, number of abnormalities seen on cardiac catheter-
zation, surgical intervention, or both; CoA, coarctation of aorta; PDA, patent ductus arteriosus; N, not performed; ARSA, aberrant right subclavian artery;
SVC, double superior venae cavae; PS, pulmonary stenosis; RAA, right aortic arch; ALSA, aberrant left subclavian artery; LSA, left subclavian artery; RAD,
etroesophageal aortic diverticulum; ARSA, aberrant right subclavian artery; LSVC, left superior vena cava; IVC, inferior vena cava; PA, pulmonary artery.ABLE E3. Summary of pulmonary vascular developmental abnormalities and associated vascular abnormalities in 9
oung patients with congenital heart diseases
ase no. Age/sex Major diagnosis Associated findings Prior procedures MRA Catheterization/operation
1 27 mo/F Pat C, PDA, LPA aneurysm, DSVC BTS 4 N/4
2 6 d/M Pat C, PDA, RPA stenosis 3 N/3
3 40 mo/M Pat C, PDA BTS 2 2/2
4 7 mo/M PS ALSA 2 2/N
5 15 mo/F PS Widened PA, PDA 3 3/N
6 8 mo/M PS Widened PA, PDA, ALSA 4 4/N
7 3 wk/M Widened PA with valve
dysplasia
PDA, RAA 3 4/4
8 6 mo/M PAPVR 1 1/N
9 4 d/F TAPVR PDA 2 N/2
RA, Number of abnormalities seen on magnetic resonance angiography; Catheterization/operation, number of abnormalities seen on cardiac catheter-
zation, surgical intervention, or both; PAt, pulmonary atresia; C, presence of pulmonary confluence; PDA, patent ductus arteriosus; LPA, left pulmonary
rtery; DSVC, double superior venae cavae; BTS, Blalock-Taussig shunt; N, not performed; RPA, right pulmonary artery; PS, pulmonary stenosis; ALSA,
berrant left subclavian artery; PA, pulmonary artery; RAA, right aortic arch; PAPVR, partial anomalous pulmonary venous return; TAPVR, total anomalous
ulmonary venous return.
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